Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Magenta Therapeutics, Inc. (MGTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2021 |
3
| Humphrey Jeffrey (Chief Medical Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 07/08/2021 |
3
| Deardorf Caren (Chief Commercial Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/15/2021 |
3
| Beetham Thomas W. (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 04/20/2021 |
3
| Nichols David Wayne (Chief Technical Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 12/23/2020 |
3
| Lawton Alison Frances (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 11/04/2020 |
3
| Mahoney Stephen F. (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/16/2020 |
3
| Olson Lisa (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 07/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/10/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2019 |
3
| McGeorge Anne (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 01/04/2019 |
3
| Ryan Jason (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Scadden David (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| ZDRAVESKI ZORAN (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Borisy Alexis (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Booth Bruce (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| ISACSON CHRISTINA K. (Chief Business Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| GV 2016 GP, L.L.C. (10% Owner) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| RONNEBERG AMY L (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| GARDNER JASON (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Driscoll Cindy (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Daniel Thomas O (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| DAVIS JOHN C. JR (Chief Medical Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| BYERS BLAKE (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| COOKE MICHAEL P. (Chief Scientific Officer) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| BONNEY MICHAEL W (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 06/20/2018 |
3
| Albers Jeffrey W. (Director) has filed a Form 3 on Magenta Therapeutics, Inc. |
|
|